145 related articles for article (PubMed ID: 24564974)
1. Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications.
Lamri L; Gripiotis E; Ferrario A
Global Health; 2014 Feb; 10():11. PubMed ID: 24564974
[TBL] [Abstract][Full Text] [Related]
2. Economic Impact of Diabetes in Africa.
Mapa-Tassou C; Katte JC; Mba Maadjhou C; Mbanya JC
Curr Diab Rep; 2019 Jan; 19(2):5. PubMed ID: 30680578
[TBL] [Abstract][Full Text] [Related]
3. Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy.
Barquera S; Campos-Nonato I; Aguilar-Salinas C; Lopez-Ridaura R; Arredondo A; Rivera-Dommarco J
Global Health; 2013 Feb; 9():3. PubMed ID: 23374611
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
Oh SH; Ku H; Park KS
BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
[TBL] [Abstract][Full Text] [Related]
5. Global policy: aspects of diabetes in India.
Bjork S; Kapur A; King H; Nair J; Ramachandran A
Health Policy; 2003 Oct; 66(1):61-72. PubMed ID: 14499166
[TBL] [Abstract][Full Text] [Related]
6. Challenges in funding diabetes care: a health economic perspective.
Weber C
Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):517-24. PubMed ID: 20950068
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review.
Bertoldi AD; Kanavos P; França GV; Carraro A; Tejada CA; Hallal PC; Ferrario A; Schmidt MI
Global Health; 2013 Dec; 9():62. PubMed ID: 24299125
[TBL] [Abstract][Full Text] [Related]
8. [Cost of diabetes mellitus in Spain].
González P; Faure E; Del Castillo A;
Med Clin (Barc); 2006 Nov; 127(20):776-84. PubMed ID: 17198665
[No Abstract] [Full Text] [Related]
9. Economic burden of thromboembolic and hemorrhagic complications in non-valvular atrial fibrillation in Algeria (the ELRAGFA study).
Bouame M; Ali Lahmar M; Bouafia MT; Hammoudi N; Chentir MT; Athmane MA; Kara S; Trancart M; Yildiz L; Cheynel J; Soualmi R
J Med Econ; 2018 Dec; 21(12):1213-1220. PubMed ID: 30238813
[TBL] [Abstract][Full Text] [Related]
10. The cost of treating type 2 diabetes (CODEIRE).
Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
[TBL] [Abstract][Full Text] [Related]
11. Diabetes in Japan: a review of disease burden and approaches to treatment.
Neville SE; Boye KS; Montgomery WS; Iwamoto K; Okamura M; Hayes RP
Diabetes Metab Res Rev; 2009 Nov; 25(8):705-16. PubMed ID: 19795421
[TBL] [Abstract][Full Text] [Related]
12. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review.
Hall V; Thomsen RW; Henriksen O; Lohse N
BMC Public Health; 2011 Jul; 11():564. PubMed ID: 21756350
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology of diabetes in urban and rural regions of Tlemcen (Western Algeria)].
Zaoui S; Biémont C; Meguenni K
Sante; 2007; 17(1):15-21. PubMed ID: 17897897
[TBL] [Abstract][Full Text] [Related]
14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
Salman RA; AlSayyad AS; Ludwig C
BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
[TBL] [Abstract][Full Text] [Related]
16. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050.
Png ME; Yoong J; Phan TP; Wee HL
BMC Public Health; 2016 Feb; 16():153. PubMed ID: 26880337
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.
Demurtas J; Alba N; Rigon G; Nesoti MV; Bovo C; Vaona A
Prim Care Diabetes; 2017 Dec; 11(6):570-576. PubMed ID: 28663023
[TBL] [Abstract][Full Text] [Related]
18. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.
Hex N; Bartlett C; Wright D; Taylor M; Varley D
Diabet Med; 2012 Jul; 29(7):855-62. PubMed ID: 22537247
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the burden of diabetes in Poland].
Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
